bearish

Kalbe Farma

Kalbe Farma (KLBF IJ) - Persisting Headwind in FY24 from Shifting Industry Trend

359 Views16 Nov 2023 20:41
Broker
Against this headwind, we project a lower FY24F earnings growth of 2.9% yoy (21-27% cut in FY23-25F est.) and cut our rating to HOLD with a lower TP of IDR1,600.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
BRI Danareksa Research
External broker reports(aggregated public sources)
BRI Danareksa Research
IndonesiaEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Kalbe Farma (KLBF IJ) - Persisting Headwind in FY24 from Shifting Industry Trend
    16 Nov 2023
x